Selective drug delivery to bone using acidic oligopeptides.
Ishizaki
Junko
J
Department of Clinical Drug Informatics, Faculty of Pharmaceutical Sciences, Kanazawa University, Kanazawa, Japan.
Waki
Yoshihiro
Y
Takahashi-Nishioka
Tatsuo
T
Yokogawa
Koichi
K
Miyamoto
Ken-Ichi
K
D000469:Alkaline Phosphatase / Q000737:chemistry / Q000378:metabolism; D000595:Amino Acid Sequence; D001842:Bone and Bones / Q000166:cytology / Q000378:metabolism*; D004337:Drug Carriers / Q000737:chemistry / Q000378:metabolism*; D016503:Drug Delivery Systems; D004958:Estradiol / Q000737:chemistry / Q000627:therapeutic use; D006801:Humans; D058574:Integrin-Binding Sialoprotein; D008969:Molecular Sequence Data; D015394:Molecular Structure; D009842:Oligopeptides / Q000737:chemistry / Q000378:metabolism; D010019:Osteomyelitis / Q000188:drug therapy; D053495:Osteopontin / Q000235:genetics / Q000378:metabolism; D010024:Osteoporosis / Q000188:drug therapy; D015363:Quinolones / Q000737:chemistry / Q000627:therapeutic use; D012795:Sialoglycoproteins / Q000235:genetics / Q000378:metabolism
D004337:Drug Carriers; C546871:IBSP protein, human; D058574:Integrin-Binding Sialoprotein; D009842:Oligopeptides; D015363:Quinolones; D012795:Sialoglycoproteins; D053495:Osteopontin; D004958:Estradiol; D000469:Alkaline Phosphatase